Economic Overview - The GDP growth for Q4 2025 is reported at 4.5%, matching expectations but down from 4.8% in the previous quarter. December retail sales growth is at 0.9%, below the expected 1.5% and previous 1.3% [12][12] - Fixed asset investment shows a cumulative year-on-year decline of 3.8%, worse than the expected decline of 2.4% and previous 2.6%. Real estate development investment has a cumulative decline of 17.2% compared to the previous 15.9% [12][12] - Industrial value-added growth for December is reported at 5.2%, exceeding the expected 4.9% and previous 4.8% [12][12] Key Changes in Economic Structure - Three significant changes are identified: improvement in service consumption, easing of the "crowding out effect" from debt reduction, and recovery in new economic sectors [12][12] - The shift in consumption policies from goods to services is noted, with service retail growth increasing while traditional retail indicators decline [12][12] - Investment slowdown is attributed to intensified corporate debt repayment policies, which ultimately benefit cash flow recovery for companies [12][12] Sector Performance - The electric grid equipment sector shows a significant increase of 60.88% over the past six months, with a daily increase of 7.01% [1] - The digital media sector has seen a decline of 4.34% yesterday, with a 21.93% increase over the past month [1] - The hotel and catering industry has increased by 3.87% yesterday and 20.46% over the past six months, indicating resilience in service consumption [1] Investment Opportunities - The report highlights potential investment opportunities in sectors benefiting from service consumption recovery and easing debt repayment pressures [12][12] - Companies in the PCB drilling needle industry are noted for their growth potential, driven by increasing demand in emerging markets [20][20] - The report suggests focusing on companies with strong cash flow recovery and those positioned in high-growth sectors such as healthcare and technology [12][12][20]

Core Insights - The data reveals significant changes in the stock holdings of various companies under the Hong Kong Stock Connect program, with notable increases and decreases in ownership percentages. Group 1: Increased Holdings - Zhongqing Holdings (01855) saw the largest increase in stock holdings, rising by 3.01% to a total holding of 13.35% [2] - Kanglong Chemical (03759) experienced a 2.91% increase, bringing its holding to 56.33% [2] - Haotian International Investment (01341) increased by 2.35%, with a current holding of 62.91% [2] - Other notable increases include Juxing Legend (06683) at +1.68% (19.00%), and Zhongwei New Materials (02579) at +1.41% (13.14%) [2] Group 2: Decreased Holdings - Goldwind Technology (02208) had the largest decrease, down by 2.28% to a holding of 47.98% [3] - China Cosco Shipping Energy Transportation (01138) decreased by 1.61%, now holding 59.13% [3] - Shandong Molong Petroleum Machinery (00568) saw a reduction of 1.59%, with a current holding of 57.08% [3] - Other significant decreases include Junda Co., Ltd. (02865) at -1.04% (48.24%) and Nanjing Panda Electronics (00553) at -0.93% (45.78%) [3] Group 3: Five-Day Changes - Junda Co., Ltd. (02865) had the highest five-day increase in holdings, up by 19.19% to 48.24% [4] - Zhongqing Holdings (01855) increased by 5.23%, reaching 13.35% [4] - Baidu's subsidiary, Baidu Apollo (02315), saw a 4.45% increase, with a holding of 19.50% [4] - Other notable increases include Zhaoyan Pharmaceutical (06127) at +4.08% (63.10%) and Weimob Group (02013) at +3.96% (30.41%) [4] Group 4: Five-Day Decreases - Huaxia Hengsheng Technology (03088) experienced the largest five-day decrease, down by 14.16% to 6.06% [4] - GF Securities (01776) decreased by 6.64%, now holding 53.59% [4] - Goldwind Technology (02208) saw a reduction of 5.22%, with a current holding of 47.98% [4] - Other significant decreases include Nanjing Panda Electronics (00553) at -4.80% (45.78%) and Chifeng Gold (06693) at -3.53% (40.57%) [4] Group 5: Twenty-Day Changes - Junda Co., Ltd. (02865) had a notable increase of 16.48%, reaching a holding of 48.24% [5] - Zhongwei New Materials (02579) increased by 10.89% to 13.14% [5] - Lion Holdings (02562) saw a rise of 9.50%, with a holding of 51.61% [5] - Other significant increases include Junsheng Electronics (00699) at +7.77% (16.56%) and Shandong Molong (00568) at +6.69% (57.08%) [5] Group 6: Twenty-Day Decreases - Huaxia Hengsheng Technology (03088) had the largest decrease of 14.15%, now holding 6.06% [5] - China Metallurgical Group (01618) decreased by 6.38%, with a holding of 35.53% [5] - GF Securities (01776) saw a reduction of 5.56%, now at 53.59% [5] - Other notable decreases include Beijing Mechanical and Electrical Holdings (00187) at -4.73% (44.59%) and China Cosco Shipping Energy Transportation (01138) at -4.66% (59.13%) [5]

2026年伊始，香港资本市场再融资活动火热开场。 公开数据显示，2025年，比亚迪435亿港元的增发成为近十年港股最大再融资项目，小米、华虹半导 体、中国宏桥、吉利汽车等一批上市公司也完成了百亿级募资。众多公司在2025年通过多次再融资，形 成了"持续补血"的格局。 港股再融资市场的活跃，得益于其制度灵活与市场回暖。 格上基金研究员托合江认为，近年来，港股再融资大发展背后的核心驱动力有二：一是2025年恒生指数 全年上涨27.77%，带来市场情绪与估值修复，为港股再融资创造了有利窗口；二是港股市场本身具备 无锁定期、快速审批、多币种发行、灵活定价等优势。 业内人士进一步阐释，香港市场的再融资制度极为高效。上市公司董事会依据股东一般性授权即可进行 配售（通常不超过已发行股份的20%），无需事前监管审批，且融资次数无限制。这种"按需融资"的机 制设计，使得企业能够迅速捕捉市场机遇，高效满足业务发展的资金需求。 止于至善投资总经理何理指出，港股再融资的多少与市场表现息息相关，融资金额大发展的背后，离不 开港股市场2024年三季度以来估值修复且成交活跃带来的市场环境，同时受到境内监管将融资资源向战 略性新兴产业倾斜的 ...

Core Viewpoint - The Hong Kong capital market has seen a significant increase in refinancing activities at the beginning of 2026, with over HKD 27 billion raised, marking a more than 20-fold increase compared to the same period in 2025, setting a vibrant tone for the year ahead [1][3]. Group 1: Active Refinancing at the Start of 2026 - As of January 18, 2026, Hong Kong-listed companies have raised over HKD 27 billion through various methods such as placements and rights issues, compared to HKD 1.1 billion in the same period of 2025 [1][3]. - The robust refinancing activity is built on the historical high of HKD 325.32 billion in 2025, which surpassed the IPO fundraising scale for the first time [3]. - Major companies like BYD and Xiaomi have completed significant fundraising projects, contributing to a trend of continuous capital replenishment [3]. Group 2: Structural Characteristics of Refinancing - The refinancing activities in early 2026 are characterized by a diverse industry distribution, including sectors like oil and gas, construction, software services, and healthcare [7]. - Notable companies such as SF Express and Jitu Express have raised over HKD 1 billion, indicating a clear differentiation in fundraising scales [7]. - The use of raised funds is closely aligned with core business strategies, including international expansion, technology R&D, and financial structure optimization [7]. Group 3: Advantages of Hong Kong's Refinancing Market - The efficiency of Hong Kong's refinancing system allows companies to quickly seize market opportunities without prior regulatory approval for placements [4]. - The flexible and diverse financing tools available in the Hong Kong market cater to various corporate needs, enhancing the ability to raise funds [5]. - The market's recovery and valuation improvements since Q3 2024 have created a favorable environment for refinancing activities [5]. Group 4: Emerging Trends in Refinancing - The refinancing landscape is evolving, with a notable increase in strategic mutual holdings among companies, exemplified by the collaboration between SF Express and Jitu Express [8]. - The current refinancing structure shows a higher proportion of traditional and consumer industries compared to emerging sectors, highlighting the complementary nature of Hong Kong and A-share markets [8]. - Future trends indicate that refinancing will remain high but with a more stable growth rate, and the focus will shift towards optimizing capital structures and enhancing R&D capabilities [10].

Core Viewpoint - The Hong Kong capital market has seen a significant increase in refinancing activities at the beginning of 2026, with over HKD 27 billion raised, marking a more than 20-fold increase compared to the same period in 2025, setting a vibrant tone for the year ahead [1][2]. Group 1: Market Activity and Trends - As of January 18, 2026, Hong Kong listed companies have raised over HKD 27 billion through various refinancing methods, a substantial increase from HKD 1.1 billion in the same period of 2025 [1]. - The 2025 Hong Kong refinancing market reached a historic high of HKD 325.32 billion, surpassing the IPO fundraising scale for the first time [1][2]. - The active refinancing market is attributed to a 27.77% increase in the Hang Seng Index in 2025, which improved market sentiment and valuation [2]. Group 2: Structural Characteristics of Financing - The refinancing activities in early 2026 show a diverse industry distribution, including sectors such as oil and petrochemicals, construction, software services, and healthcare [3]. - Notable companies like SF Express and Jitu Express raised over HKD 10 billion each, while 10 other companies raised over HKD 1 billion [3]. - The primary use of raised funds is aligned with core business strategies, including international expansion, technology R&D, and financial structure optimization [3]. Group 3: Financing Methods and Innovations - Placement remains the dominant method for refinancing, with 27 out of 36 cases in 2026 utilizing this approach, highlighting its efficiency and flexibility [3]. - A notable trend in 2026 is the diversification of financing methods, including strategic mutual holdings through consideration issuance, which promotes industry chain integration [4][5]. - The issuance of convertible bonds, particularly zero-coupon convertible bonds, is becoming increasingly active, with financing concentrating on leading enterprises [6]. Group 4: Future Outlook - The Hong Kong refinancing market is expected to maintain high activity levels, with a stable growth rate and continued demand from capital-intensive industries [6]. - The flexible and efficient issuance system is likely to attract more listed companies, with refinancing volumes expected to exceed IPOs [6]. - The importance of hard technology and biotechnology companies is anticipated to rise, while the participation of cross-border capital is expected to enhance market liquidity [6].

Market Overview - The Hong Kong stock market showed a weak performance today, with all three major indices closing lower. The Hang Seng Index fell by 1.05% to 26,563.90 points, the Tech Index dropped by 1.24% to 5,749.98 points, and the National Enterprises Index decreased by 0.94% to 9,134.45 points [1]. Aviation Sector - The aviation sector performed strongly today, with notable gains in airline stocks. China Eastern Airlines rose by 9.20%, China Southern Airlines increased by 6.29%, and Air China gained 3.76% [3][4]. - According to Huachuang Securities, the aviation industry is expected to show a clear recovery trend in 2025, with Spring Airlines reporting a 12.1% year-on-year increase in both capacity (ASK) and passenger turnover (RPK) [4]. Energy and Power Sector - The energy and power sector saw a collective rise, with companies like Dongfang Electric increasing by 6.38% and Harbin Electric by 5.46% [5]. - The market recognizes the value of power equipment companies as essential components of AI computing infrastructure, with significant investments expected in this sector by 2026 [5]. Pharmaceutical Sector - Pharmaceutical stocks generally retreated, with notable declines in companies such as Viva Biotech, which fell by 5.83%, and WuXi Biologics, which dropped by 4.83% [6][7]. - Despite the short-term pressure on stock prices, the fundamentals of the pharmaceutical research service industry are improving, with a double-digit growth in new orders for several CRO companies [7][8]. AI Application Sector - Stocks in the internet healthcare and AI application sectors continued to decline, with Ping An Good Doctor down by 4.41% and Ark Health by 3.75% [9][10]. - Analysts from CITIC Securities noted that the trend of accelerating commercialization in the AI application field remains unchanged, with ongoing product iterations indicating user growth and business model exploration [10]. Individual Stock Movements - Jinxin Fertility reported a 5.28% increase, attributed to continued improvement in its fourth-quarter operational data, with a narrowing decline in IVF cycles [12]. - New World Department Store China surged by 29.51% following recent personnel changes, including the appointment of new leadership [13].

Group 1 - The core viewpoint of the article highlights that 康龙化成 (Crown Bioscience) is experiencing a decline in stock price, dropping over 3% to HKD 22.12, with a trading volume of HKD 113 million [2] - On January 15, 康龙化成 announced a plan to place nearly 58.44 million new H-shares at a price of HKD 22.82 per share, representing an approximate 8.5% discount to the closing price on January 14, aiming to raise a net amount of about HKD 1.319 billion [2] - Approximately 70% of the funds raised will be allocated to project construction to enhance laboratory service facilities, drug process development, and production capacity [2] Group 2 - 康龙化成 recently released an earnings forecast, projecting a net profit attributable to shareholders for 2025 to be between HKD 1.614 billion and HKD 1.686 billion, reflecting a decrease of 6% to 10% compared to the previous year [2] - During the reporting period, the company's operating revenue is expected to grow by 13% to 16%, while the net profit after excluding non-recurring gains and losses is anticipated to increase by 36% to 41% year-on-year [2]

每经AI快讯，康龙化成(03759.HK)再跌超3%，截至发稿跌3.41%，报22.12港元，成交额1.13亿港元。 ...

Core Viewpoint - Kanglong Chemical (03759) has seen a decline of over 3%, currently trading at HKD 22.12, with a transaction volume of HKD 113 million [1] Group 1: Fundraising and Stock Issuance - On January 15, Kanglong Chemical announced a plan to issue nearly 58.44 million new H-shares at a price of HKD 22.82 per share, representing a discount of approximately 8.5% compared to the closing price on January 14 [1] - The net proceeds from this fundraising are expected to be around HKD 1.319 billion, with approximately 70% allocated for project construction to enhance laboratory service facilities, drug process development, and production capacity [1] Group 2: Earnings Forecast - Kanglong Chemical recently released an earnings forecast, projecting a net profit attributable to shareholders for 2025 to be between HKD 1.614 billion and HKD 1.686 billion, indicating a year-on-year decline of 6% to 10% [1] - During the reporting period, the company's operating revenue is expected to grow by 13% to 16%, while the net profit after excluding non-recurring gains and losses is anticipated to increase by 36% to 41% year-on-year [1]

消息面上，1月15日，康龙化成发布公告，拟配售近5844.08万股新H股，配售价每股22.82港元，较1月 14日收市价折让约8.5%，募资所得款项净额约13.19亿港元，其中约70%将用于公司的项目建设，以加 强实验室服务设施、药物工艺开发及生产设施的能力及产能。 康龙化成（300759）(03759)再跌超3%，截至发稿，跌3.41%，报22.12港元，成交额1.13亿港元。 此外，康龙化成近日公布业绩预告，预计2025年归属于上市公司股东的净利润为16.14亿元-16.86亿元， 比上年同期下降6%-10%。报告期内，公司营业收入同比增长13%-16%，扣除非经常性损益后的净利润 同比增长36%-41%。 ...